ABBV

AbbVie (ABBV), classified in the Health Care sector, has drawn disclosed trading activity from 24 distinct members of Congress across 88 total transactions spanning from May 2020 through June 2026, reflecting sustained and relatively broad congressional interest over a multi-year window. The balance of activity leans toward selling, with 48 sales against 40 purchases, and the most active disclosers by transaction count include Josh Gottheimer, Ro Khanna, Lisa McClain, and Daniel Goldman. Four bipartisan co-trading clusters are recorded in the public disclosure data, meaning members from both parties appear in overlapping transaction windows, and 27 executive-branch officials have separately disclosed 57 transactions in the same security, with the closest congressional and executive purchases falling two days apart within the public filing record — a sequence observed across independent disclosures. Congressional trading in ABBV is among the more broadly distributed in the Health Care sector by member count, though the net selling posture and bipartisan spread suggest a range of individual portfolio decisions rather than a concentrated directional pattern.